跳至主要内容
临床试验/ISRCTN38841716
ISRCTN38841716进行中(未招募)未知

Development of a digital biomarker and intervention for subclinical depression: Study protocol for a longitudinal waitlist control study

ETH Zurich0 个研究点目标入组 200 人开始时间: 2022年8月20日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37349832/ (added 23/06/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 18 years old and over
  • 2. Residency in Switzerland
  • 3. Understand of mid-level English or German (B1-B2)

排除标准

  • 1. Current diagnosis with or in treatment for a mental health disease
  • 2. Asthma, COPD, or any other lung or respiratory tract disease
  • 3. Pregnancy
  • 4. Scoring greater than 15 for symptom severity of depression and anxiety in the PHQ-9 and GAD-7 instruments, respectively
  • 5. Positive response to the last question of the PHQ-9, accessing suicide ideation or self-harm

研究者

发起方
ETH Zurich

相似试验